Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides
Authors:
Open Access
- 5 March 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 46 (7) , 3579-3594
Abstract
Chemically modified antisense oligonucleotides (ASOs) with phosphorothioate (PS) linkages have been extensively studied as research and therapeutic agents. PS-ASOs can enter the cell and trigger cleavage of complementary RNA by RNase H1 even in the absence of transfection reagent. A number of cell surface proteins have been identified that bind PS-ASOs and mediate their cellular uptake; however, the mechanisms that lead to productive internalization of PS-ASOs are not well understood. Here, we characterized the interaction between PS-ASOs and epidermal growth factor receptor (EGFR). We found that PS-ASOs trafficked together with EGF and EGFR into clathrin-coated pit structures. Their co-localization was also observed at early endosomes and inside enlarged late endosomes. Reduction of EGFR decreased PS-ASO activity without affecting EGF-mediated signaling pathways and overexpression of EGFR increased PS-ASO activity in cells. Furthermore, reduction of EGFR delays PS-ASO trafficking from early to late endosomes. Thus, EGFR binds to PS-ASOs at the cell surface and mediates essential steps for active (productive) cellular uptake of PS-ASOs through its cargo-dependent trafficking processes which migrate PS-ASOs from early to late endosomes. This EGFR-mediated process can also serve as an additional model to better understand the mechanism of intracellular uptake and endosomal release of PS-ASOs.Keywords
This publication has 47 references indexed in Scilit:
- Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug deliveryOral Oncology, 2010
- Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptorNucleic Acids Research, 2010
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic PlatformAnnual Review of Pharmacology and Toxicology, 2010
- Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosisNucleic Acids Research, 2008
- Structure of two intramolecular G-quadruplexes formed by natural human telomere sequences in K + solution †Nucleic Acids Research, 2007
- Progress in Antisense TechnologyAnnual Review of Medicine, 2004
- Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular DomainsCell, 2002
- Cellular Specificity for the Activation of Fibroblast Growth Factor-2 by Heparan Sulfate ProteoglycanBiochemical and Biophysical Research Communications, 2001
- Interaction of Activated EGF Receptors with Coated Pit AdaptinsScience, 1993
- Rotational mobility of high-affinity epidermal growth factor receptors on the surface of living A431 cellsBiochemistry, 1991